tradingkey.logo
tradingkey.logo

Zoetis Inc

ZTS
View Detailed Chart
115.930USD
+0.700+0.61%
Close 03/24, 16:00ETQuotes delayed by 15 min
57.97BMarket Cap
19.23P/E TTM

Zoetis Inc

115.930
+0.700+0.61%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.61%

5 Days

-4.73%

1 Month

-9.89%

6 Months

-18.17%

Year to Date

-7.86%

1 Year

-28.95%

View Detailed Chart

TradingKey Stock Score of Zoetis Inc

Currency: USD Updated: 2026-03-24

Key Insights

Zoetis Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 30 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 147.32.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Zoetis Inc's Score

Industry at a Glance

Industry Ranking
30 / 157
Overall Ranking
104 / 4547
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Zoetis Inc Highlights

StrengthsRisks
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.66%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.66%.
Undervalued
The company’s latest PE is 19.23, at a low 3-year percentile range.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 1.11K shares of this stock.

Analyst Rating

Based on 21 analysts
Buy
Current Rating
147.319
Target Price
+27.36%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Zoetis Inc Info

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Ticker SymbolZTS
CompanyZoetis Inc
CEOPeck (Kristin C)
Websitehttps://www.zoetis.com/
KeyAI